Dr. Litvak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
94 Old Short Hills Rd
Livingston, NJ 07039Phone+1 973-322-5650
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Johns Hopkins UniversityResidency, Internal Medicine, 2009 - 2012
Baylor College of MedicineClass of 2009
Certifications & Licensure
NJ State Medical License 2015 - 2025
NY State Medical License 2012 - 2015- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- AOA
Publications & Presentations
PubMed
- 131 citationsBiomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update.Fabrice Andre, Nofisat Ismaila, Kimberly H Allison, William E Barlow, Deborah E Collyar
Journal of Clinical Oncology. 2022-06-01 - 27 citationsExceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers.Alexander Drilon, Adam J. Schoenfeld, Kathryn C. Arbour, Anna Maria Litvak, Ai Ni
Cold Spring Harbor Molecular Case Studies. 2019-04-01 - 53 citationsStage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.Natasha Rekhtman, Patrice Desmeules, Anna Maria Litvak, M.C. Pietanza, Maria Lauren Santos-Zabala
Modern Pathology. 2019-03-28
Press Mentions
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
